United Therapeutics Corporation logo

United Therapeutics Corporation

NASDAQ:UTHR

Overview | Financials
Company Name United Therapeutics Corporation
Symbol UTHR
Currency USD
Price 301.42
Market Cap 13,596,031,372
Dividend Yield 0%
52-week-range 260.41 - 417.82
Industry Biotechnology
Sector Healthcare
CEO Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D.
Website https://www.unither.com

An error occurred while fetching data.

About United Therapeutics Corporation

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated

Related Stocks

Jazz Pharmaceuticals plc logo

Jazz Pharmaceuticals plc

JAZZ

97.78 USD

Maravai LifeSciences Holdings, Inc. logo

Maravai LifeSciences Holdings, Inc.

MRVI

1.98 USD

Bruker Corporation logo

Bruker Corporation

BRKR

37.52 USD

Henry Schein, Inc. logo

Henry Schein, Inc.

HSIC

68.64 USD

Exact Sciences Corporation logo

Exact Sciences Corporation

EXAS

51.63 USD

Repligen Corporation logo

Repligen Corporation

RGEN

123.24 USD

DENTSPLY SIRONA Inc. logo

DENTSPLY SIRONA Inc.

XRAY

15.81 USD

Neurocrine Biosciences, Inc. logo

Neurocrine Biosciences, Inc.

NBIX

115.71 USD

Financials

Numbers are in millions USD

Numbers are in millions USD